Tantalus System

DEVICE2 trials

Sponsors

MetaCure (USA), Inc.

Conditions

Diabetes Mellitus, Type 2

Unknown Phase

The TANTALUS® II for the Treatment of Type 2 Diabetes

CompletedNCT01303302

MetaCure (USA), Inc.Diabetes Mellitus, Type 2

Start: 2008-04-30End: 2015-08-31Updated: 2016-09-22

The TANTALUS® II for the Treatment of Type 2 Diabetes

CompletedNCT01303302

MetaCure (USA), Inc.Diabetes Mellitus, Type 2

Start: 2008-04-30End: 2015-08-31Updated: 2016-09-22

TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy

TerminatedNCT01303315

MetaCure (USA), Inc.Diabetes Mellitus, Type 2

Start: 2011-01-31End: 2011-07-31Updated: 2016-09-22